Accordingly, PD-1 blockade may facilitate the proliferation of highly suppressive PD-1+ Treg cells in hyperprogressive cancer, which results in inhibition of effector T cells in tumor tissues (187). This evidence concerns the gene PDCD1 and neoplasm.